ArticleBiomaterials2027
Nano-layered tendon patch to orchestrate timely interactions between tendon stem/progenitor cells and macrophages.
Article in Biomaterials, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Tendon regeneration remains limited by the unmet challenge of precisely controlling the intensity and duration of local inflammation, often resulting in scarred healing. Here, we present a novel, micro-thin, nano-layered patch that employs Layer-by-Layer (LbL) self-assembly for the precisely controlled release of small molecules, Oxo-M and 4-PPBP, to address this technical challenge. This novel combination of small molecules exhibits distinct functions in modulating the polarization of macrophages and the tenogenic differentiation of tendon stem/progenitor cells (TSCs). The customized, temporal release of these small molecules effectively modulated the critical crosstalk between TSCs and macrophages, thereby promoting regenerative tendon healing. The nano-LbL tendon patch successfully mitigated early inflammation, promoted matrix synthesis, and regulated later tissue remodeling in vivo. Robust scRNA-seq and CellChat analysis delineated the temporal-orchestrated communication between cell types across healing phases, confirming the critical interplays between TSCs, tenocytes, and macrophages. We then validated the key signaling pathways regulating cell-cell communication modulating inflammation. Our nano-layered LbL nanopatch represents a highly translational approach for achieving scarless tendon regeneration. In addition, this study elucidated the essential signaling pathways regulating TSC-macrophage crosstalk, advancing our understanding of tendon biology and pathology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.